PATIENTS' PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES. (May 2023) - Zeidan, A.; Perepezko, K.; Salimi, T.; Washington, T.; Epstein, R.